Skip to main content
SpringerLink
Log in

The effect of molybdate on the intracellular distribution of estrogen receptor in mammary tumors

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The addition of sodium molybdate (20 mM) to human breast tumor homogenates results in an increased yield of estrogen receptor sites in the cytosol, but reduces the number of sites detectable in salt extracts of purified nuclei. Only about 25% of the increase in cytosol receptor can be accounted for by the loss of nuclear sites. Addition of molybdate to isolated nuclear salt extracts has no inhibitory effect on the estrogen receptor assay, but addition of the oxyanion to the cytosol after separation of the initial nuclear pellet still gives a significant increase in estradiol binding capacity. Furthermore, addition of molybdate to the suspension from the first nuclear pellet still results in loss of binding sites in the nuclear salt extract. This rules out the possibility that the negative effect of molybdate on nuclear receptor recovery is by its inhibition of cytosol receptor activation and translocation during tissue preparation.

The number of nuclei isolated from estrogen receptor-containing tumors does not differ significantly in the presence or absence of molybdate. Estrogen receptor-negative tumors however yield fewer nuclei, particularly when they are processed in the presence of molybdate.

We conclude that when homogenization of tumors is carried out in the presence of molybdate, a significant fraction of estrogen receptor which would normally be present in purified nuclei is lost, perhaps by leakage through the nuclear membrane.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Miller LK, Tuazon FB, Niu EM, Sherman MR: Human breast tumor estrogen receptor: effects of molybdate and electrophoretic analysis. Endocrinology 108: 1369–1378, 1981

    PubMed  Google Scholar 

  2. Niu EM, Neal RM, Pierce VK, Sherman MR: Structural similarity of molybdate-stabilized steroid receptors in human breast tumors, uteri and leukocytes. J Steroid Biochem 15: 1–18, 1981

    Google Scholar 

  3. Gaubert GM, Blancucci S, Shyamala G: A comparison of the cytoplasmic estrogen receptors of mammary gland from virgin and lactating mice. Endocrinology 110: 683–685,1982

    PubMed  Google Scholar 

  4. Anderson KM, Phelan J, Marogel M, Hendrickson C, Economou S: Sodium molybdate increases the amount of progesterone and estrogen receptor detected in certain human breast cancer cytosols. Steroids 35: 273–280, 1980

    PubMed  Google Scholar 

  5. Krozowski ZS, Murphy LC: Stabilization of the cytoplasmic oestrogen receptor by molybdate. J Steroid Biochem 14: 363–366, 1981

    PubMed  Google Scholar 

  6. Gaubert CM, Tremblay RR, Dubé JY: Effect of sodium molybdate on cytosolic androgen receptors in rat prostate. J Steroid Biochem 13: 931–936, 1980

    PubMed  Google Scholar 

  7. Hawkins EF, Lieskovsky G, Markland FS Jr: Molybdate and the measurement of androgen receptors in prostate cancer. J Clin Endocrinol Metab 53: 456–458, 1981

    PubMed  Google Scholar 

  8. McGuire WL, Carbone PP, Sears ME, Escher GC: Estrogen receptors in human breast cancer: an overview.In McGuire WL, Carbone PP, Vollmer EP (eds): Estrogen Receptors in Human Breast Cancer. Raven Press, New York, 1975, pp 1–7

    Google Scholar 

  9. McGuire WL: Steroid hormone receptors in breast cancer treatment strategy. Rec Prog Hor Res 36: 135–156, 1980

    Google Scholar 

  10. Leake RE, Laing L, Calman KC, MacBeth FR, Crawford DR, Smith DC: Oestrogen-receptor status and endocrine therapy of breast cancer: response rates and status stability. Br J Cancer 43: 59–66, 1981

    PubMed  Google Scholar 

  11. Hawkins RA, Roberts MM, Forrest APM: Oestrogen receptors and breast cancer: current status. Brit J Surg 67: 153–169, 1980

    PubMed  Google Scholar 

  12. Panko WB, McLeod RM: Uncharged nuclear receptors for estrogen in breast cancers. Cancer Res 38: 1948–1951, 1978

    PubMed  Google Scholar 

  13. Thorsen T: Occupied and unoccupied nuclear oestradiol receptor in human breast tumors: relation to estradiol and progesterone cytosol receptors. J Steroid Biochem 10: 661–668, 1979

    PubMed  Google Scholar 

  14. Leake RE, Laing L, McArdle C, Smith DC: Soluble and nuclear oestrogen receptor status in human breast cancer in relation to prognosis. Br J Cancer 43: 67–72, 1981

    PubMed  Google Scholar 

  15. Sato B, Nomura Y, Nakao K, Ochi H, Matsumoto K: DNA binding ability of estrogen receptor from human breast cancer. J Steroid Biochem 14: 295–303, 1981

    PubMed  Google Scholar 

  16. Fazekas AG, MacFarlane JK: Studies on cytosol and nuclear binding of estradiol in human breast cancer. J Steroid Biochem 13: 613–622, 1980

    PubMed  Google Scholar 

  17. McGuire WL, Zava DT, Horwitz KB, Garola RE, Chamness GC: Receptors and breast cancer: Do we know it all? J Steroid Biochem 9: 461–466, 1978

    PubMed  Google Scholar 

  18. Syne JS, Markaverich BM, Clark JH, Panko WB: Estrogen binding sites in the nucleus of normal and malignant human tissue: optimization of an exchange assay for the measurement of specific binding. Cancer Res 42: 4443–4448, 1982

    PubMed  Google Scholar 

  19. Syne JS, Markaverich BM, Clark JH, Panko WB: Estrogen binding sites in the nucleus of normal and malignant human tissue: characteristics of the multiple nuclear binding sites. Cancer Res 42: 4449–4454, 1982

    PubMed  Google Scholar 

  20. Osborne CK, Yochmowitz MG, Knight WA, McGuire WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884–2888, 1980

    PubMed  Google Scholar 

  21. Edwards DP, Adams DJ, McGuire WL: Specific protein synthesis regulated by estrogen in human breast cancer. J Steroid Biochem 15: 247–259, 1981

    PubMed  Google Scholar 

  22. Edwards DP, Martin PM, Horwitz KB, Chamness GC, McGuire WL: Subcellular compartmentalization of estrogen receptors in human breast cancer cells. Exptl Cell Res 127: 197–213, 1980

    PubMed  Google Scholar 

  23. McGuire WL, DeLaGarza M, Chamness GC: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res 37: 637–639, 1977

    PubMed  Google Scholar 

  24. Lieskovsky G, Bruchovsky N: Assay of nuclear androgen receptor in human prostate. J Urol 121: 54–58, 1979

    PubMed  Google Scholar 

  25. Burton K: A study of the conditions and mechanisms of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315–323, 1956

    PubMed  Google Scholar 

  26. Leach Kl, Dahmer MK, Hammond WD, Sando JJ, Pratt WB: Molybdate inhibition of glycocorticoid receptor inactivation and transformation. J Biol Chem 254: 11884–11890, 1979

    PubMed  Google Scholar 

  27. Noma K, Nakao K, Sato B, Nishizawa Y, Matsumoto K, Yamamura Y: Effect of molybdate on activation and stabilization of steroid receptors. Endocrinology 107: 1205–1211, 1980

    PubMed  Google Scholar 

  28. Steel RGD, Torrie JH: Principles and Procedures of Statistics. McGraw-Hill, New York, 1960, p 405

    Google Scholar 

  29. Osborne CK, Fisher E, Redmond C, Knight WA, Yochmowitz MG, McGuire WL: Estrogen receptor, a marker for human breast cancer differentiation and patient prognosis.In Leavitt WW (ed): Hormones and Cancer, Plenum, New York, 1982, pp 377–385

    Google Scholar 

  30. Trachtenberg J, Hicks LL, Walsh PC: Methods for the determination of androgen receptor content in human prostatic tissue. Invest Urol 18: 349–254, 1981

    PubMed  Google Scholar 

  31. Barrack ER, Bujnovszky P, Walsh PC: Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors. Cancer Res 43: 1107–1116, 1983

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Dalhousie University, B3H 4H7, Halifax, Nova Scotia, Canada

    Catherine B. Lazier Ph.D., Janice Richman B.Sc. & Kim Lonergan B.Sc.

Authors
  1. Catherine B. Lazier Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janice Richman B.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kim Lonergan B.Sc.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lazier, C.B., Richman, J. & Lonergan, K. The effect of molybdate on the intracellular distribution of estrogen receptor in mammary tumors. Breast Cancer Res Tr 4, 19–26 (1984). https://doi.org/10.1007/BF01806984

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806984

Keywords

Search

Navigation